155734-85-3

Upstream product

• 75-77-4 chloro-trimethyl-silane 
• 39172-32-2 2-(3-bromophenyl)-2-methyl-[1,3]dioxolane 
• 2142-63-4 1-(3-Bromophenyl)ethanone 

Downstream Products

• 151957-63-0 (2R,3S)-3-(3'-iodophenyl)butane-1,2-diol 
• 151774-89-9 (E)-3-<3'-(trimethylsilyl)phenyl>-2-buten-1-ol 
• 22161-82-6 (+)-α-(3-benzylphenyl)propionic acid 
• 151957-59-4 (S)-2-(3'-iodophenyl)propanoic acid 
• 173436-86-7 (RS)-2-(3'-iodophenyl)propanoic acid 
• 151774-87-7 ethyl (E)-3-<3'-(trimethylsilyl)phenyl>-2-butenoate 
• 151774-91-3 (2S,3S)-3-methyl-3-<3'-(trimethylsilyl)phenyl>oxiranemethanol 
• 151774-97-9 (4R,1'S)-4-<1'-(3''-bromophenyl)ethyl>-2,2-dimethyl-1,3-dioxolane 
• 151774-95-7 (2R,3S)-3-<3'-(trimethylsilyl)phenyl>butane-1,2-diol 

Relevant academic research and scientific papers

Enantioselective syntheses of 2-arylpropanoic acid non-steroidal antiinflammatory drugs and related compounds

(S)-2-[4′-(2″-Methylpropyl)phenylpropanoic acid (ibuprofen) and (S)-2-(3′-benzoylphenyl)propanoic acid (ketoprofen) have been synthesised in high enantiomeric excess. Control of stereochemistry was achieved by a combination of Sharpless epoxidalion followed by catalytic hydrogenolysis of the introduced benzylic epoxide oxygen bond. Also, the coupling of organic compounds in the presence of palladium with enantiopure 2-(3-iodophenyl)propanoic and 2-(4-iodophenyl)propanoic acids, prepared by the methodology above, is a general method for the synthesis of optically active arylpropanoic acids.

Heterocyclic dihydrazole compounds and their use for controlling fungal plant diseases

PCT No. PCT/US96/06533 Sec. 371 Date Nov. 13, 1997 Sec. 102(e) Date Nov. 13, 1997 PCT Filed May 8, 1996 PCT Pub. No. WO96/36633 PCT Pub. Date Nov. 21, 1996Compounds of Formula I, and their N-oxides and agriculturally suitable salts, are disclosed which ar